Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167375 · ClinicalTrials.gov registry record
Testing the Nocturnal Sleep Latency Profile in Primary Insomnia
A clinical trial of Sleep Initiation and Maintenance Disorders and Primary Insomnia, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT00167375 is a study of Sleep Initiation and Maintenance Disorders and Primary Insomnia that has completed, run by University of Pittsburgh. The registered enrollment target is 24 participants, below the 289-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00167375, a study of Sleep Initiation and Maintenance Disorders and Primary Insomnia, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and are different between controls and patients with primary insomnia. The primary insomnia patients then go on to have about 2 weeks of an insomnia intervention. Then the new kind of study is repeated in the patients. The controls only are examined in baseline studies.
Conditions Studied
Interventions
- DRUG eszopiclone 3 mg qHS
- BEHAVIORAL General cognitive/behavioral interventions for insomnia
Study Locations (1)
Pennsylvania
- Western Psychiatric Institute and Clinic - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167375
The ClinicalTrials.gov registry entry for NCT00167375 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 289-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (92% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Initiation and Maintenance Disorders appearing as the primary indexed condition, and to 2 interventions - of which eszopiclone 3 mg qHS is the first listed.
NCT00167375 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00167375 about?
NCT00167375 is a clinical study titled "Testing the Nocturnal Sleep Latency Profile in Primary Insomnia". This study tests a new kind of sleep study in which subjects are awakened 2 times after initially going to sleep. The study focuses on the EEG signal process as a person goes to sleep. The general hypothesis is that the signal properties are stable from night to night during baseline studies, and ar...
What is the current status of trial NCT00167375?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2005-01. Estimated completion is 2007-06.
What conditions does trial NCT00167375 study?
This clinical trial studies the following conditions: Sleep Initiation and Maintenance Disorders, Primary Insomnia.
What interventions are being tested in trial NCT00167375?
The interventions under investigation include: eszopiclone 3 mg qHS (DRUG), General cognitive/behavioral interventions for insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT00167375?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167375 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Initiation and Maintenance Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Optimizing Sleep Health in Nurses
RECRUITING · NA
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk
RECRUITING · NA
-
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
RECRUITING · Phase 4
-
A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Sleep Initiation and Maintenance Disorders
All registered trials for this condition
Primary Insomnia
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.